|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-3-5
|
|
pubmed:abstractText |
This pilot study investigated effectiveness and tolerability of risperidone for the treatment of psychosis and agitation in 9 inpatients with Parkinson's disease and dementia. Investigators found risperidone to be effective and safe, without worsening extrapyramidal symptoms or further impairing cognition.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0895-0172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
594-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9447503-Aged,
pubmed-meshheading:9447503-Antipsychotic Agents,
pubmed-meshheading:9447503-Dementia,
pubmed-meshheading:9447503-Female,
pubmed-meshheading:9447503-Humans,
pubmed-meshheading:9447503-Male,
pubmed-meshheading:9447503-Parkinson Disease,
pubmed-meshheading:9447503-Pilot Projects,
pubmed-meshheading:9447503-Psychiatric Status Rating Scales,
pubmed-meshheading:9447503-Psychomotor Agitation,
pubmed-meshheading:9447503-Risperidone
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
|
|
pubmed:affiliation |
Veterans Affairs Medical Center, Houston, Texas 77030, USA. workman.richardvhvjr@houston.va.gov
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
